Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sumitomo Dainippon Pharma Co (4506) vs. Competitors

7 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
JP:4506Sumitomo Dainippon Pharma CoJPY 1,819.50JPY 850.31B17.06-32.66%Moderate BuyUnlock the JP:4506 analyst price target with TipRanks PremiumJP:4506Unlock the JP:4506 top-analyst price target with TipRanks Premium
JP:4523Eisai CoJPY 5,280.00JPY 1.50T33.9512.65%―Unlock the JP:4523 analyst price target with TipRanks PremiumJP:4506 vs JP:4523Unlock the JP:4523 top-analyst price target with TipRanks Premium
JP:4547Kissei Pharmaceutical CoJPY 4,370.00JPY 183.61B16.210.58%HoldUnlock the JP:4547 analyst price target with TipRanks PremiumJP:4506 vs JP:4547Unlock the JP:4547 top-analyst price target with TipRanks Premium
JP:4507Shionogi & CoJPY 3,121.00JPY 2.79T11.0114.81%Moderate BuyUnlock the JP:4507 analyst price target with TipRanks PremiumJP:4506 vs JP:4507Unlock the JP:4507 top-analyst price target with TipRanks Premium
JP:4502Takeda Pharmaceutical CoJPY 6,973.00JPY 11.09T28.4856.66%Moderate BuyUnlock the JP:4502 analyst price target with TipRanks PremiumJP:4506 vs JP:4502Unlock the JP:4502 top-analyst price target with TipRanks Premium
JP:4516Nippon Shinyaku Co., Ltd.JPY 3,302.00JPY 227.86B7.56-8.89%HoldUnlock the JP:4516 analyst price target with TipRanks PremiumJP:4506 vs JP:4516Unlock the JP:4516 top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
JP:4506Sumitomo Dainippon Pharma Co1819.50-792.50-30.34%
JP:4523Eisai Co5280.00753.2316.64%
JP:4547Kissei Pharmaceutical Co4370.0035.730.82%
JP:4507Shionogi & Co3121.00487.9018.53%
JP:4502Takeda Pharmaceutical Co6973.002686.9962.69%
JP:4516Nippon Shinyaku Co., Ltd.3302.00-219.85-6.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts